Financing

Key figures on December 31, 2016

Net debt, MEUR 321.7
Net debt/EBITDA  1.36 (cumulative)
Net gearing, %  53.9 
Equity ratio, %  48.4 
Average interest of the loan portfolio, %  2.2

 

At present, DNA does not have a credit rating.

More information on the management of credit risks in note 3 to financial statements >>

Primary sources of financing, 31 December 2016

EUR 80 million Danske, Nordea, Pohjola, SHB & SEB
EUR 100 million Bond I, coupon rate 2.625%
EUR 150 million Bond II, coupon rate 2.875%
EUR 34 million EIB
EUR 5 million Commercial papers

Financing reserves

Amount Utilised
Revolving credit facility of EUR 150 million Fully undrawn
Commercial paper programme of EUR 150 million EUR 5 million

DNA’s financial covenants

Equity ratio:
31 December, 2016: 48.4 %
Limit: 35.0 %

Net debt / EBITDA (rolling 12 months): 
31 December, 2016: 1.36
Limit: 3.50